Trial Details
RECRUITINGBasic Information
| Clinical ID | c1262 |
|---|---|
| Identifier | NCT04372108 |
| Trial Title | A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Colitis, Ulcerative |
| Interventions | DRUG: Ustekinumab|DRUG: Other Biologic Therapies |
Participant Information
| Sponsor | Janssen Scientific Affairs, LLC |
|---|---|
| City | Portsmouth |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2021-06-24 |
|---|---|
| Primary Completion Date | 2029-08-31 |
| Completion Date | 2030-08-30 |